PMID: 16518967Mar 8, 2006Paper

A human neutralizing antibody against a conformational epitope shared by oligomeric SARS S1 protein

Antiviral Therapy
Jin-Zhu DuanXi-Yun Yan

Abstract

An antibody phage-display library was constructed from the B cells of convalescent severe acute respiratory syndrome (SARS) patients and screened using inactivated SARS coronavirus (CoV) virions as antigens. More than 80 positive clones were isolated from the library and one of them, scFv H12, was extensively characterized. scFv H12 bound to SARS-CoV with high affinity (equilibrium dissociation constant, Kd=73.5 nM), and neutralized SARS virions in vitro. The facts that scFv H12 bound to the SARS-S1 protein under non-reducing conditions and that it did not bind to monomeric S1 protein under reducing conditions strongly suggest that scFv H12 recognizes a conformational epitope shared by oligomeric S1 proteins. This study should aid in the manufacture of neutralizing antibody, provide a better understanding the immunological characteristics of SARS protein and facilitate the design of a SARS vaccine.

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Related Papers

Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Jin-Zhu DuanXi-Yun Yan
Nature Reviews. Microbiology
B OlowokureJ S Mackenzie
The Lancet Infectious Diseases
Georgina Kenyon
Connecticut Medicine
Dorothy Levine
CJEM
John M Tallon
© 2021 Meta ULC. All rights reserved